T1	TimeInfo 0 6	1 Jahr
T2	Medication 37 46	triple IS
T3	Medication 51 54	CyA
T4	Condition 61 64	BKV
T5	Medication 75 78	MMF
T6	Medication 94 98	mTOR
T7	LabValues 103 107	Krea
T8	Measure 108 115	Anstieg
T9	LabValues 125 128	DSA
T10	LabValues 135 139	Krea
T11	Measure 151 159	steigend
T12	Measure 171 183	kontrolliert
T13	Measure 188 195	2 mg/dl
T15	LabValues 197 199	PU
T16	Measure 204 209	1,4 g
T17	HealthState 211 217	stabil
R1	has_Measure arg1:T7 arg2:T8
R2	has_Measure arg1:T10 arg2:T11
R3	has_Measure arg1:T10 arg2:T12
R4	has_Measure arg1:T15 arg2:T16
T18	Tx_middle 0 14	1 Jahr nach TX
R5	has_Measure arg1:T10 arg2:T13	
R6	has_State arg1:T15 arg2:T17	
A1	Risk T18 risk_factor
T14	Condition 16 26	Borderline
T20	Temporal 16 36	Borderline Fr√ºhphase
A2	Temporal_Element T20 past
A3	Risk T14 increase_risk_factor
T21	Temporal 0 14	1 Jahr nach TX
A4	Temporal_Element T21 present
T22	Temporal 37 55	triple IS mit CyA,
A5	Temporal_Element T22 present
A6	Risk T2 decrease_risk_factor
A7	Risk T3 risk_factor
T23	Measure 65 74	Reduktion
R8	has_Measure arg1:T5 arg2:T23	
A8	Risk T5 increase_risk_factor
A9	Risk T4 increase_risk_factor
A10	Risk T7 increase_symptom
A11	Risk T6 risk_factor
A12	Risk T9 increase_risk_factor
A13	Risk T10 increase_symptom
A14	Risk T15 increase_symptom
T24	Temporal 135 195	Krea sukzessive steigend, aber noch kontrolliert bei 2 mg/dl
A15	Temporal_Element T24 past_present
T25	Temporal 197 218	PU bei 1,4 g (stabil)
A16	Temporal_Element T25 present
T26	Temporal 56 78;79 115	nach BKV Reduktion MMF Umstellung auf mTOR bei Krea Anstieg
A17	Temporal_Element T26 past_present
T27	Temporal 116 134	Nachweis DSA (neu)
A18	Temporal_Element T27 present
